Effect of aspiration pneumonia-induced sepsis on post-burn cardiac inflammation and function in mice

Surgical Infections

Volumn 7, Issue 2, 2006, Pages 123-135

  Horton, Jureta W ^a   Maass, David ^a   White, Jean ^a   Sanders, Billy ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CYTOKINE; RINGER LACTATE SOLUTION; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPIRATION PNEUMONIA; BODY SURFACE; BURN; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE EXACERBATION; DISEASE MODEL; DISEASE PREDISPOSITION; FEMALE; FLUID RESUSCITATION; GENETIC ENGINEERING; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEART FUNCTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HYPOTHESIS; IMMUNE RESPONSE; IN VITRO STUDY; INFECTION SENSITIVITY; ISOLATED HEART; KLEBSIELLA PNEUMONIAE; MALE; MOUSE; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; SEPSIS; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; BURNS; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; HEART; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICE; MICE, INBRED C57BL; MYOCARDIAL CONTRACTION; MYOCARDITIS; MYOCYTES, CARDIAC; PNEUMONIA, ASPIRATION; PNEUMONIA, PNEUMOCOCCAL; SEPSIS; VENTRICULAR FUNCTION, LEFT;

EID: 33646671916     PISSN: 10962964     EISSN: None     Source Type: Journal    
DOI: 10.1089/sur.2006.7.123     Document Type: Article

References (43)

1. Sittig K, Deitch EA. Effect of bacteremia on mortality after thermal injury. Arch Surg 1998;123:1367-1370.
2. Neely AN, Bhattacharjee AK, Babcock GF, et al. Differential effects of two different routes of immunization on protection against gram-negative sepsis by a detoxified Escherichia coli J5 lipopolysaccharide Group B meningococcal outer membrane protein complex vaccine in a burned mouse model. J Burn Care Rehabil 2002;23:333-340.
3. Pruit BA, McManus AT, Kim SH, Goodwin CW. Burn wound infections: Current status. World J Surg 1998; 22:135-145.
4. Pruitt BA. Infection and the burn patient. Br J Surg 1990;77:1081-1082.
5. Fitzwater J, Purdue GF, Hunt JL, O'Keefe GE. The risk factors and time course of sepsis and organ dysfunction after burn trauma. J Trauma 2003;54:959-966.
6. Bang RL, Sharma PN, Sanyal SC, Najjadah AL. Septicemia after burn injury: A comparative study. Burns 2002;28:746-51.
7. Kobayashi M, Takahashi H, Sanford AP, et al. An increase in the susceptibility of burned patients to infectious complications due to impaired production of macrophage inflammatory protein 1 alpha. J Immunol 2002;169:4460-4466.
8. Davis KA, Santaniello JM, He LK, et al. Burn injury and pulmonary sepsis: Development of a clinically relevant model. J Trauma. 2004;56:272-278.
9. de Macedo JL, Rosa SC, Castro C. Sepsis in burned patients. Rev Soc Bras Med Trop 2003;36:647-652.
10. Shirani KZ, Pruit BA, Mason AD. The influence of inhalation injury and pneumonia on burn mortality. Ann Surg 1987;205:82-87.
11. Wurtz R, Karajovic M, Dacumos E, et al. Nosocomial infections in a burn intensive care unit. Burns 1995;21:181-184.
12. Sheeran PW, Maass DL, White DJ, et al. Aspiration pneumonia-induced sepsis increases cardiac dysfunction after burn trauma. J Surg Res 1998;76:192-199.
13. Horton JW, Maass DL, White DJ, Sanders B. Myocardial inflammatory responses to sepsis complicated by previous burn injury. Surg Infect 2003;4:363-377.
14. Baker CC, Miller CL, Trunkey DD. Predicting fatal sepsis in burn patients. J Trauma 1979;19:641-648.
15. Baker CC, Chaudry RH, Gaines HO, Baue AE. Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery 1983;94:331-335.
16. Moss NM, Gough DB, Jordan AL, et al. Temporal correlation of impaired immune response after thermal injury with susceptibility to infection in a murine model. Surgery 1988;104:882-887.
17. Wolfe JHN, Wu AVO, O'Connor NE, et al. Anergy, immunosuppressive serum, and impaired lymphocyte blastogenesis in burn patients. Arch Surg 1982;117:1266-1271.
18. Wood JJ, Rodrick ML, O'Mahony JB, et al. Impaired production of interleukin 2: A fundamental immunological deficiency in patients with major burns. Ann Surg 1984;200:311-320.
19. White J, Maass DL, Horton JW. Development of acute burn model in adult mice for studies of cardiac function and cardiomyocyte cellular function. Shock 2001;16:122-129.
20. Adams HR, Baxter CR, Izenberg SD. Decreased contractility and compliance of the left ventricle as complications of thermal trauma. Am Heart J 1984;108: 1477-1483.
21. Horton JW, White DJ, Maass DL, et al. Antioxidant vitamin therapy alters burn trauma-mediated cardiac NF-κB activation and cardiomyocyte cytokine secretion. J Trauma 2001;50:397-408.
22. Horton JW, Tan J, White DJ, et al. Selective decontamination of the digestive tract attenuated the myocardial inflammation and dysfunction that occur with burn injury. Am J Physiol Heart Circ Physiol 2004;287:2241-2251.
23. Horton JW, Garcia NM, White DJ, Keffer J. Postburn cardiac contractile function and biochemical markers of postburn cardiac injury. J Am Coll Surg 1995; 181:289-298.
24. Sasaki J, Fujishima S, Iwamura H, et al. Prior burn insult induces lethal acute lung injury in endotoxemic mice: Effects of cytokine inhibition. Am J Physiol Lung Cell Mol Physiol 2003;284:L270-L278.
25. Shelley O, Murphy T, Paterson H, et al. Interaction between the innate and adaptive immune systems is required to survive sepsis and control inflammation after injury. Shock 2003;20:123-129.
26. Deitch EA. Multiple organ failure: Pathology and potential future therapy. Am Surg 1992;216:117-134.
27. Moore FA, Moore EE. Evolving concepts in the pathogenesis of post injury multiple organ failure. Surg Clin North Am 1995;75:251-277.
28. Pallua N, Von Heimburg D. Pathogenic role of interleukin-6 in the development of sepsis I: Study in a standardized contact burn murine model. Crit Care Med 2003;31:1490-1494.
29. Pallua N, Low JF, Von Heimburg D. Pathogenic role of interleukin-6 in the development of sepsis II: Significance of anti-interleukin-6 and soluble interleukin-5 receptor-alpha antibodies in a standardized murine contact burn model. Crit Care Med 2003;31: 1495-1501.
30. Ozbalkan Z, Aslar AK, Yildiz Y, Aksaray S. Investigation of the course of proinflammatory and anti-inflammatory cytokines after burn sepsis. Int J Clin Pract 2004;58:125-129.
31. Klein D, Einspanier R, Bolder U, Jeschke MG. Differences in the hepatic signal transcription pathway and cytokine expression between thermal injury and sepsis. Shock 2003;20:536-543.
32. Maass DL, Hybki Peters D, White J, Horton JW. The time course of cardiac NF-κB activation and TNF-α secretion by cardiac myocytes after burn injury: Contribution to burn-related cardiac contractile dysfunction. Shock 2002;17:293-299.
33. Giroir BP, Horton JW, White DJ, McIntyre KL, Lin CQ. Inhibition of tumor necrosis factor prevents myocardial dysfunction during burn shock. Am J Physiol 1994;267:H118-H124.
34. Maass DL, White J, Horton JW. IL-6 and IL-1β act synergistically with TNF-α to alter cardiac contractile function after burn trauma. Shock 2002;18:360-366.
35. Natansom C, Eichenholz PW, Danner RL, et al. Endotoxin and tumor necrosis factor challenge in dogs stimulate the cardiovascular profile of human septic shock. J Exp Med 1989;169:823-831.
36. Yokoyama T, Vaca L, Rossen RD, et al. Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. J Clin Invest 1993;92:2303-2212.
37. Bick RJ, Jing-Piin L, King TW, et al. Temporal effects of cytokines on neonatal cardiac myocyte calcium transients and adenylate cyclase activities. Am J Physiol Heart Circ Physiol 1997;272:H1937-H1944.
38. Horton JW, Maass DL, White DJ, Sanders B. Hypertonic saline dextran suppresses burn-related cytokine synthesis by cardiomyocytes. Am J Physiol Heart Circ Physiol 2001;280:H1591-H1601.
39. Bartlett JG, Mundy LM. Community-acquired pneumonia. N Engl J Med 1995;333:1618-1624.
40. Frantz S, Kelly RA, Bourcier T. Role of TLR-2 in the activation of nuclear factor kappaB by oxidative stress in cardiac myocytes. J Biochem 2001;276:5797-5803.
41. Frantz S, Kobzik L., Kim YD, et al. Toll-4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J Clin Invest 1999;104:271-280.
42. Yokoyama T, Vaca L, Rossen RD, et al. Cellular basis for the negative inotropic effects of tumor necrosis factor-α in the adult mammalian heart. J Clin Invest 1993;92:2303-2312.
43. Meldrum DR, Cleveland JC, Cran BS, et al. Increased myocardial tumor necrosis factor-alpha in a crystalloid-perfused model of cardiac ischemia-reperfusion injury. Ann Thorac Surg 1998;65:439-443.